38 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Apctm1Rak/Apc+ Cdh1tm1Cbm/Cdh1+ involves: 129P2/OlaHsd * C57BL/6J	increased intestinal adenocarcinoma incidence	J:65142
	increased stomach tumor incidence	J:65142
Cdh1tm1.1Mpst/Cdh1tm2Kem Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Tg(Vil1-cre)20Syr/0 involves: 129 * C57BL/6 * DBA/2	no abnormal phenotype detected	J:163273
Cdh1tm1Jjon/Cdh1+ Trp53tm1Brn/Trp53tm1Brn Tg(KRT14-cre)8Brn/0 involves: 129P2/OlaHsd * FVB/N	increased mammary adenocarcinoma incidence	J:116152
	increased pilomatricoma incidence	J:116152
	increased skin tumor incidence	J:116152
	increased squamous cell carcinoma incidence	J:116152
Cdh1tm1Jjon/Cdh1+ Trp53tm1Brn/Trp53tm1Brn Tg(Wap-cre)51Nki/0 involves: 129P2/OlaHsd * FVB/N	increased mammary adenocarcinoma incidence	J:171765
	increased mammary gland tumor incidence	J:171765
Cdh1tm1Jjon/Cdh1tm1Jjon Trp53tm1Brn/Trp53+ Tg(KRT14-cre)8Brn/0 involves: 129P2/OlaHsd * FVB/N	abnormal tumor vascularization	J:116152
	increased mammary adenocarcinoma incidence	J:116152
	increased metastatic potential	J:116152
	increased skin tumor incidence	J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon Trp53tm1Brn/Trp53+ Tg(Wap-cre)51Nki/0 involves: 129P2/OlaHsd * FVB/N	hypolactation	J:171765
	increased mammary gland tumor incidence	J:171765
	increased metastatic potential	J:171765
Cdh1tm1Jjon/Cdh1tm1Jjon Trp53tm1Brn/Trp53tm1Brn Tg(KRT14-cre)8Brn/0 involves: 129P2/OlaHsd * FVB/N	abnormal tumor vascularization	J:116152
	increased mammary adenocarcinoma incidence	J:116152
	increased metastatic potential	J:116152
	increased skin tumor incidence	J:116152
Cdh1tm1Jjon/Cdh1tm1Jjon Trp53tm1Brn/Trp53tm1Brn Tg(Wap-cre)51Nki/0 involves: 129P2/OlaHsd * FVB/N	abnormal mammary gland duct morphology	J:171765
	abnormal mammary gland growth during pregnancy	J:171765
	abnormal mammary gland lobule morphology	J:171765
	increased mammary gland tumor incidence	J:171765
	increased metastatic potential	J:171765
	lactation failure	J:171765
Cdh1tm2.1Mpst/Cdh1tm2.1Mpst involves: C57BL/6 * FVB/N	absent blastocoele	J:183847
	absent trophectoderm	J:183847
	increased trophectoderm apoptosis	J:183847
Cdh1tm2Kem/Cdh1+ Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0 involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N	normal neoplasm	J:212549
Cdh1tm2Kem/Cdh1+ Smad4tm2.1Cxd/Smad4tm2.1Cxd Trp53tm1Brn/Trp53tm1Brn Tg(MMTV-cre)7Mul/0 involves: 129 * C57BL/6 * FVB/N	increased mammary adenocarcinoma incidence	J:212549
	increased metastatic potential	J:212549
Cdh1tm2Kem/Cdh1+ Smad4tm2.1Cxd/Smad4tm2.1Cxd Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0 involves: 129 * C57BL/6 * FVB/N	increased duodenum adenocarcinoma incidence	J:212549
	increased gastric adenocarcinoma incidence	J:212549
	increased metastatic potential	J:212549
	increased squamous cell carcinoma incidence	J:212549
	premature death	J:212549
Cdh1tm2Kem/Cdh1+ Smad4tm2.1Cxd/Smad4tm2.1Cxd Trp53tm1Brn/Trp53tm1Brn Tg(Vil1-cre)20Syr/0 involves: 129 * C57BL/6 * DBA/2	increased intestinal adenocarcinoma incidence	J:212549
Cdh1tm2Kem/Cdh1tm2Kem Smad4tm2.1Cxd/Smad4tm2.1Cxd Trp53tm1Brn/Trp53tm1Brn Tg(Pdx1-cre)6Tuv/0 involves: 129 * C57BL/6 * FVB/N	increased gastric adenocarcinoma incidence	J:212549
Cdh1tm2Kem/Cdh1tm2Kem Tg(KRT14-cre)1Efu/0 Tg(Krt14-RNAi:Cdh3)1Efu/0 involves: 129S1/Sv * 129X1/SvJ	abnormal epidermal layer morphology	J:144091
	abnormal epidermis stratum basale morphology	J:144091
	abnormal epidermis stratum spinosum morphology	J:144091
	abnormal epidermis suprabasal layer morphology	J:144091
	abnormal skin condition	J:144091
	abnormal skin physiology	J:144091
	blistering	J:144091
	decreased birth body size	J:144091
	decreased hair follicle number	J:144091
	flaky skin	J:144091
	impaired skin barrier function	J:144091
	neonatal lethality, complete penetrance	J:144091
	shiny skin	J:144091
	thick epidermis	J:144091
	tight skin	J:144091
Cdh1tm3.1Mpst/Cdh1tm3.1Mpst involves: C57BL/6 * FVB/N	abnormal trophectoderm morphology	J:183847